相关实验视频

Updated: Jul 20, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

USP13通过通过稳定ALDOA抑制铁亡来改善心肌梗塞损伤

Pengcheng Li¹, Delong Chen¹, Chenyun Zhang¹

¹Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China; State Key Laboratory of Transvascular Implantation Devices, Hangzhou, 310009, China; Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou, 310009, China.

|January 7, 2026

概括

乌比基特异性蛋白酶13 (USP13) 通过防止铁亡,在心肌梗塞 (MI) 后保护心脏. 升级USP13可能为心脏损伤提供一种新疗法.

科学领域:

生物化学生物化学
心血管生物学心血管生物学
分子医学是分子医学.

背景情况:

脱基酶 (DUBs) 对蛋白质平衡至关重要,但它们在心肌梗塞 (MI) 后心脏重塑中的作用尚未完全理解.
应激反应性DUB与心脏损伤有关,但具体的目标和机制在很大程度上仍未被描述.

研究的目的:

为了研究在心脏病发作后心脏损伤中全素特异蛋白酶13 (USP13) 的作用.
阐明USP13影响心脏重塑和铁亡的分子机制.

主要方法:

利用MI的小鼠模型来评估心脏功能和损伤.
采用生物化学测试来确定USP13-ALDOA相互作用和脱活动.
研究了USP13缺乏和过度表达对心肌细胞铁和心脏重塑的影响.

主要成果:

在MI引起的心脏损伤时,USP13表达显著下调.
USP13缺乏症加剧了心脏铁和MI后的功能障碍.
USP13直接对果糖二酸盐阿尔多酶A (ALDOA) 进行二基化和稳定,防止其蛋白质体降解并抑制铁亡.
过度表达USP13在小鼠中减弱MI诱导的心脏损伤.

结论:

USP13通过稳定ALDOA和抑制铁亡作用,作为预防心肌梗塞引起的心脏损伤的保护因素.
USP13代表了心肌梗塞的潜在治疗标,提供了一种新的策略,专注于抑制铁亡.

关键词:

心脏损伤是因为心脏损伤.心肌梗塞的心脏病发作 USP13 美国在Ubiquitination中使用.

更多相关视频

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

相关概念视频

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...